Brain Advance Access originally published online on October 26, 2005
Brain 2005 128(12):2961-2976; doi:10.1093/brain/awh644
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Olfactory ensheathing glial co-grafts improve functional recovery in rats with 6-OHDA lesions
Department of Neuroscience, Karolinska Institutet, S-171 77 Stockholm, Sweden
Correspondence to: Saga Johansson, Department of Neuroscience, Karolinska Institutet, S-171 77 Stockholm, Sweden E-mail: saga.johansson{at}neuro.ki.se
Olfactory ensheathing cells (OEC) transplanted to the site of a spinal cord injury can promote axonal sparing/regeneration and functional recovery. The purpose of this study was to investigate if OEC enhance the effects of grafted dopamine-neuron-rich ventral mesencephalic tissue (VM) in a rodent model of Parkinson's disease. We co-grafted VM with either OEC or astrocytes derived from the same olfactory bulbs as the OEC to rats with a unilateral 6-hydroxydopamine lesion of the nigrostriatal system. Co-grafting fetal VM with OEC, but not with astrocytes enhanced dopamine cell survival, striatal reinnervation and functional recovery of amphetamine- and apomorphine-induced rotational behaviour compared with grafting embryonic VM alone. Grafting OEC or astrocytes alone had no effects. Intriguingly, only in the presence of OEC co-grafts, did dopamine neurons extend strikingly long neurites that reached peripheral striatal compartments. Comparable results were observed in a co-culture system where OEC promoted dopamine cell survival and neurite elongation through a mechanism involving both releasable factors and direct contact. Cell type analysis of fetal VM grafts suggested that dopamine neurons of the substantia nigra rather than of the ventral tegmental area were increased in the presence of OEC co-grafts. We conclude that the addition of OEC enhances efficacy of grafted immature dopamine neurons in a rat Parkinson's disease model.
Key Words: transplantation; dopamine neurons; olfactory ensheathing cells; astrocytes; Parkinson's disease
Abbreviations: GFAP = glial fibrillary acidic protein; OEC = olfactory ensheathing cells; SN = substantia nigra; VM = ventral mesencephalic tissue
Received March 1, 2005. Revised August 16, 2005. Accepted August 30, 2005.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
W. Murrell, A. Wetzig, M. Donnellan, F. Feron, T. Burne, A. Meedeniya, J. Kesby, J. Bianco, C. Perry, P. Silburn, et al. Olfactory Mucosa Is a Potential Source for Autologous Stem Cell Therapy for Parkinson's Disease Stem Cells, August 1, 2008; 26(8): 2183 - 2192. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pan, G. Wang, H.-Q. Yang, Z. Hong, Q. Xiao, R.-J. Ren, H.-Y. Zhou, L. Bai, and S.-D. Chen K252a Prevents Nigral Dopaminergic Cell Death Induced by 6-Hydroxydopamine through Inhibition of Both Mixed-Lineage Kinase 3/c-Jun NH2-Terminal Kinase 3 (JNK3) and Apoptosis-Inducing Kinase 1/JNK3 Signaling Pathways Mol. Pharmacol., December 1, 2007; 72(6): 1607 - 1618. [Abstract] [Full Text] [PDF] |
||||

